Review



kn92 422709  (Millipore)


Bioz Verified Symbol Millipore is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Millipore kn92 422709
    Kn92 422709, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kn92+422709/kn+92/pmc11725171-117-15-26
    Average 90 stars, based on 1 article reviews
    kn92 422709 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Control:

    Article Title: Substance P induces plasticity and synaptic tagging/capture in rat hippocampal area CA2
    Article Snippet: The CaMKIV inhibitor KN-93 (1 mg in solution; no. 422712; Calbiochem) and its corresponding inactive control KN92 (solid; no. 422709; Calbiochem) were stored at −20 °C as a 10-mM stock in DMSO and diluted with aCSF to achieve a final concentration of 10 μM.

    Article Title: Spinal astrocyte-derived interleukin-17A promotes pain hypersensitivity in bone cancer mice
    Article Snippet: 2-[N-(2-hydroxyethyl)-N-(4methoxybenzenesulfonyl)] amino-N-(4-chlorocinnamyl)-N-methylbenzylamine (KN93, 422708) and 2-[N-(4-methoxybenzenesulfonyl)] amino-N-(4-chlorocinnamyl)N-methylbenzylamine (KN92, 422709) were obtained from Calbiochem.

    Concentration Assay:

    Article Title: Substance P induces plasticity and synaptic tagging/capture in rat hippocampal area CA2
    Article Snippet: The CaMKIV inhibitor KN-93 (1 mg in solution; no. 422712; Calbiochem) and its corresponding inactive control KN92 (solid; no. 422709; Calbiochem) were stored at −20 °C as a 10-mM stock in DMSO and diluted with aCSF to achieve a final concentration of 10 μM.

    Article Title: Spinal astrocyte-derived interleukin-17A promotes pain hypersensitivity in bone cancer mice
    Article Snippet: 2-[N-(2-hydroxyethyl)-N-(4methoxybenzenesulfonyl)] amino-N-(4-chlorocinnamyl)-N-methylbenzylamine (KN93, 422708) and 2-[N-(4-methoxybenzenesulfonyl)] amino-N-(4-chlorocinnamyl)N-methylbenzylamine (KN92, 422709) were obtained from Calbiochem.



    Similar Products

    90
    Millipore kn92 422709
    Kn92 422709, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kn92+422709/kn+92/pmc11725171-117-15-26
    Average 90 stars, based on 1 article reviews
    kn92 422709 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Merck KGaA kn92 (cat. no. 422709)
    A. Relative gene expression of OCT4, NANOG, MYC, and KLF4 in ZRLC-1 or HCC827 cells treated with DMSO, <t>KN92,</t> or KN93. Data are expressed as mean ± SEM of n = 3 independent cell dishes per condition. * p < 0.05, ** p < 0.01, *** p < 0.001 versus cells treated with KN92. B. Detection of Oct4, c-Myc, pCaMKIIγ, and GAPDH protein by western blots in ZRLC-1 or HCC827 cells treated with DMSO, KN92, or KN93. C. Quantitative analysis of oncosphere formation by 3000 ZRLC-1 or HCC827 cells treated with DMSO, KN92, or KN93. Data are expressed as mean ± SEM of n = 3 independent cell dishes per condition. * p < 0.05 versus cells treated with KN92. D. ZRLC-1 or HCC827 cells pre-treated with KN92 or KN93 were separately injected subcutaneously into nude mice. Data are expressed as mean ± SEM of n = 5 mice per group. * p < 0.05, ** p < 0.01. NS: no significance. Tumor incidence is displayed on the graph.
    Kn92 (Cat. No. 422709), supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kn92+422709/kn+92/pmc04599257-147-4-31
    Average 90 stars, based on 1 article reviews
    kn92 (cat. no. 422709) - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    A. Relative gene expression of OCT4, NANOG, MYC, and KLF4 in ZRLC-1 or HCC827 cells treated with DMSO, KN92, or KN93. Data are expressed as mean ± SEM of n = 3 independent cell dishes per condition. * p < 0.05, ** p < 0.01, *** p < 0.001 versus cells treated with KN92. B. Detection of Oct4, c-Myc, pCaMKIIγ, and GAPDH protein by western blots in ZRLC-1 or HCC827 cells treated with DMSO, KN92, or KN93. C. Quantitative analysis of oncosphere formation by 3000 ZRLC-1 or HCC827 cells treated with DMSO, KN92, or KN93. Data are expressed as mean ± SEM of n = 3 independent cell dishes per condition. * p < 0.05 versus cells treated with KN92. D. ZRLC-1 or HCC827 cells pre-treated with KN92 or KN93 were separately injected subcutaneously into nude mice. Data are expressed as mean ± SEM of n = 5 mice per group. * p < 0.05, ** p < 0.01. NS: no significance. Tumor incidence is displayed on the graph.

    Journal: Oncotarget

    Article Title: Ca 2+ /calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells

    doi:

    Figure Lengend Snippet: A. Relative gene expression of OCT4, NANOG, MYC, and KLF4 in ZRLC-1 or HCC827 cells treated with DMSO, KN92, or KN93. Data are expressed as mean ± SEM of n = 3 independent cell dishes per condition. * p < 0.05, ** p < 0.01, *** p < 0.001 versus cells treated with KN92. B. Detection of Oct4, c-Myc, pCaMKIIγ, and GAPDH protein by western blots in ZRLC-1 or HCC827 cells treated with DMSO, KN92, or KN93. C. Quantitative analysis of oncosphere formation by 3000 ZRLC-1 or HCC827 cells treated with DMSO, KN92, or KN93. Data are expressed as mean ± SEM of n = 3 independent cell dishes per condition. * p < 0.05 versus cells treated with KN92. D. ZRLC-1 or HCC827 cells pre-treated with KN92 or KN93 were separately injected subcutaneously into nude mice. Data are expressed as mean ± SEM of n = 5 mice per group. * p < 0.05, ** p < 0.01. NS: no significance. Tumor incidence is displayed on the graph.

    Article Snippet: KN93 (Cat. No. 422711), KN92 (Cat. No. 422709), Akt Inhibitor IV (Cat. No. 124011), β-catenin/Tcf Inhibitor V (Cat. No. 219334), and Wnt Pathway inhibitor XI (Cat. No. 681674) were purchased from Merck Millipore.

    Techniques: Expressing, Western Blot, Injection

    A. Detection of Akt and β-catenin signals in H1299 parental or oncosphere cells by western blots. B. Detection of Akt and β-catenin signals in H1299 cells tranduced with control or CaMKIIγ vector by western blots. C. Detection of Akt and β-catenin signals in ZRLC-1 cells treated with DMSO, KN92, or KN93 by western blots. D. Detection of Oct4 and c-Myc in CaMKIIγ-overexpressed H1299 cells treated with Akt or β-catenin inhibitor by western blots. E. Lysates of CaMKIIγ-overexpressed A549 and H1299 cells were incubated with CaMKIIγ or Akt antibody for immunoprecipitation and the immune complex was then purified, separated by SDS-PAGE, and immunoblotted with Akt or CaMKIIγ antibody. F. Dual luciferase reporter assay of Wnt pathway (TOP, FOP, and the ratio of TOP/FOP) in control or CaMKIIγ-overexpressed H1299 cells. Data are expressed as mean ± SEM of n = 4 independent cell dishes per condition. ** p < 0.01. G. Quantitative western blot analysis of oncosphere formation by control or CaMKIIγ-overexpressed A549 or H1299 cells treated with Akt or β-catenin inhibitor. Data are expressed as mean ± SEM of n = 4 independent cell dishes per condition. * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: Oncotarget

    Article Title: Ca 2+ /calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells

    doi:

    Figure Lengend Snippet: A. Detection of Akt and β-catenin signals in H1299 parental or oncosphere cells by western blots. B. Detection of Akt and β-catenin signals in H1299 cells tranduced with control or CaMKIIγ vector by western blots. C. Detection of Akt and β-catenin signals in ZRLC-1 cells treated with DMSO, KN92, or KN93 by western blots. D. Detection of Oct4 and c-Myc in CaMKIIγ-overexpressed H1299 cells treated with Akt or β-catenin inhibitor by western blots. E. Lysates of CaMKIIγ-overexpressed A549 and H1299 cells were incubated with CaMKIIγ or Akt antibody for immunoprecipitation and the immune complex was then purified, separated by SDS-PAGE, and immunoblotted with Akt or CaMKIIγ antibody. F. Dual luciferase reporter assay of Wnt pathway (TOP, FOP, and the ratio of TOP/FOP) in control or CaMKIIγ-overexpressed H1299 cells. Data are expressed as mean ± SEM of n = 4 independent cell dishes per condition. ** p < 0.01. G. Quantitative western blot analysis of oncosphere formation by control or CaMKIIγ-overexpressed A549 or H1299 cells treated with Akt or β-catenin inhibitor. Data are expressed as mean ± SEM of n = 4 independent cell dishes per condition. * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: KN93 (Cat. No. 422711), KN92 (Cat. No. 422709), Akt Inhibitor IV (Cat. No. 124011), β-catenin/Tcf Inhibitor V (Cat. No. 219334), and Wnt Pathway inhibitor XI (Cat. No. 681674) were purchased from Merck Millipore.

    Techniques: Western Blot, Plasmid Preparation, Incubation, Immunoprecipitation, Purification, SDS Page, Luciferase, Reporter Assay

    A. Detection of acetylation and methylation of histone in control or CaMKIIγ-overexpressed H1299 cells by western blots. B. Detection of acetylated histone3 (H3Ac) in ZRLC-1 cells treated with DMSO, KN92, or KN93 by western blots. C. Detection of H3Ac, Oct4, and c-Myc in KN93-treated ZRLC-1 cells cultured with TSA by western blots. D. Detection of H3Ac in control or CaMKIIγ-overexpressed H1299 cells treated with Akt inhibitor by western blots. E. CHIP-enriched DNA from control or CaMKIIγ-overexpressed H1299 cells treated with Akt inhibitor using anti-H3Ac antibody is amplified by real-time PCR, depending on primers designed according to the transcription regulatory region of OCT4. Data are expressed as enrichment assessed relative to the input DNA ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001. F. Detection of histone acetylation transferases in control or CaMKIIγ-overexpressed H1299 cells by western blots. G. Detection of histone acetylation transferases in H1299 parental or oncosphere cells by western blots. (H) CHIP-enriched DNA from control or CaMKIIγ-overexpressed H1299 cells treated with Akt inhibitor using anti-PCAF antibody is amplified by real-time PCR, depending on primers designed according to the transcription regulatory region of OCT4. Data are expressed as enrichment assessed relative to the input DNA ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: Oncotarget

    Article Title: Ca 2+ /calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells

    doi:

    Figure Lengend Snippet: A. Detection of acetylation and methylation of histone in control or CaMKIIγ-overexpressed H1299 cells by western blots. B. Detection of acetylated histone3 (H3Ac) in ZRLC-1 cells treated with DMSO, KN92, or KN93 by western blots. C. Detection of H3Ac, Oct4, and c-Myc in KN93-treated ZRLC-1 cells cultured with TSA by western blots. D. Detection of H3Ac in control or CaMKIIγ-overexpressed H1299 cells treated with Akt inhibitor by western blots. E. CHIP-enriched DNA from control or CaMKIIγ-overexpressed H1299 cells treated with Akt inhibitor using anti-H3Ac antibody is amplified by real-time PCR, depending on primers designed according to the transcription regulatory region of OCT4. Data are expressed as enrichment assessed relative to the input DNA ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001. F. Detection of histone acetylation transferases in control or CaMKIIγ-overexpressed H1299 cells by western blots. G. Detection of histone acetylation transferases in H1299 parental or oncosphere cells by western blots. (H) CHIP-enriched DNA from control or CaMKIIγ-overexpressed H1299 cells treated with Akt inhibitor using anti-PCAF antibody is amplified by real-time PCR, depending on primers designed according to the transcription regulatory region of OCT4. Data are expressed as enrichment assessed relative to the input DNA ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: KN93 (Cat. No. 422711), KN92 (Cat. No. 422709), Akt Inhibitor IV (Cat. No. 124011), β-catenin/Tcf Inhibitor V (Cat. No. 219334), and Wnt Pathway inhibitor XI (Cat. No. 681674) were purchased from Merck Millipore.

    Techniques: Methylation, Western Blot, Cell Culture, Amplification, Real-time Polymerase Chain Reaction